Showing results (21-30 of 194) with videos related to

Sort By:
Pageof 20
Frontiers in Immunology|February 23, 2023
Preemptive interferon-α therapy could prevent relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: A real-world analysisShuang Fan, Tian-Zhong Pan, Li-Ping Dou, et al.
Clinical Transplantation|July 29, 2025
The Impact of Blast Percentage on Posttransplant Outcomes of Patients With Myelodysplastic Syndromes: A Retrospective Analysis Within the IPSS-M FrameworkZhong-Shi Lyu, Yu-Qian Sun, Xiao-Dong Mo, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2020
Incidence, Risk Factors, and Outcomes of Primary Prolonged Isolated Thrombocytopenia after Haploidentical Hematopoietic Stem Cell TransplantFei-Fei Tang, Yu-Qian Sun, Xiao-Dong Mo, et al.
Annals of Hematology|February 9, 2023
Prognostic factors for patients with hematologic malignancies admitted to the intensive care unit: is allogeneic transplantation still a risk factor?Pei-Hua Wu, Wen-Xuan Huo, Xiao-Dong Mo, et al.
Annals of Hematology|March 25, 2020
A retrospective analysis on anti-CD20 antibody-treated Epstein-Barr virus-related posttransplantation lymphoproliferative disorder following ATG-based haploidentical T-replete hematopoietic stem cell transplantationXue-Yi Luo, Xiao-Dong Mo, Lan-Ping Xu, et al.
Bone Marrow Transplantation|July 17, 2025
Characteristics and prognosis of central nervous system relapse after allogeneic hematopoietic stem cell transplantation in adult patients with leukemiaLi-Ping Guo, Li-Juan Hu, Xiao-Dong Mo, et al.
European Journal of Haematology|January 21, 2026
Bridging With Chimeric Antigen Receptor T-Cell Therapy or Chemotherapy to Allo-HSCT in B-ALL: A Comparison of Treatment Complications and SurvivalNing Wu, Jun Kong, Meng Lv, et al.
Clinical Immunology (Orlando, Fla.)|April 27, 2026
The impact of pre-existing autoimmune diseases in myelodysplastic syndrome patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective cohort studyNing Wu, Jing Liu, Meng Lv, et al.
Frontiers in Immunology|October 8, 2021
Meta-Analysis of Interleukin-2 Receptor Antagonists as the Treatment for Steroid-Refractory Acute Graft-Versus-Host DiseaseMeng-Zhu Shen, Jing-Xia Li, Xiao-Hui Zhang, et al.
Annals of Hematology|November 7, 2020
Ruxolitinib is an effective salvage treatment for multidrug-resistant graft-versus-host disease after haploidentical allogeneic hematopoietic stem cell transplantation without posttransplant cyclophosphamideJiao-Yu Zhao, Si-Ning Liu, Lan-Ping Xu, et al.
Pageof 20